Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients.
about
Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.A brief historical review of the waterfall/cascade of blood coagulation.Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settingsRecombinant factor VIIa in the treatment of non-hemophiliac bleeding.The safety and efficacy of the administration of recombinant activated factor VII in major surgery and trauma patients.Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhageMechanistic implications for the use and monitoring of recombinant activated factor VII in trauma.Recombinant activated factor VIIa and hemostasis in critical care: a focus on traumaManagement of bleeding emergencies: when to use recombinant activated factor VII.Recombinant coagulation factor VIIa--a novel haemostatic agent in scoliosis surgery?Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trialRecombinant factor VIIa in paediatric bleeding disorders--a 2006 review.Recombinant Factor VIIa for Bleeding in Non-hemophiliac Pediatric Patients.The influence of coagulation and inflammation research on the improvement of polytrauma care.Recombinant factor VIIa reduces bleeding risk in patients on platelet aggregation inhibitors immediately prior to renal transplantation--a retrospective analysis.Management of life-threatening hemorrhages and unsafe interventions in nonhemophiliac children by recombinant factor VIIa.Recombinant factor VIIa for refractory bleeding following orthotopic heart transplantation.Successful treatment with rFVIIa of spontaneous intracerebral hemorrhage in a patient with mechanical prosthetic heart valves.
P2860
Q33370641-63A170B0-E593-4264-A1CB-7DC36E19BEC3Q35564946-8071220A-2892-4C67-ACF8-F383D9B3D2D2Q35578941-CFCE1D29-3156-48CC-A67B-72412193C669Q36077574-1B43A976-0E92-41A5-AF6E-EDA2A728D81DQ36150578-B787DEAE-AE6E-4043-9F55-2E7918BF5853Q36256080-C3BAFF9A-BC28-43BE-AF76-6898A3AEB144Q36284640-FD7EFEFF-2654-4077-BEC3-C4CC35224B54Q36284647-2F950D5A-1CC1-4884-898C-5D438AA06E3BQ36349585-6BF2A66E-20B0-4445-BBC3-AA8B296B9A3EQ36372563-087957E0-547D-4231-8ABC-941CEE3A841DQ36392691-777550BA-BA36-46C1-A5EF-4469593BE0DAQ36570888-35CE0CDB-2376-4D9E-923C-65EB0D0577D4Q38051320-8D40BF1F-3187-4B4B-AA9B-9E64E891C360Q39611127-867221DC-E8AC-4264-968E-FEFF0084F312Q40243256-4CD4B821-1E44-4F8B-9064-DCB02B97E8C2Q43664321-B4054D11-9EED-4BF3-BFE5-3B22791884FFQ50787850-FA2C4EDB-E9B3-47DB-97CF-8C1E7DC315B8Q51387316-5D0C8768-0C17-4672-AAA1-64A008C6FFAF
P2860
Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Recombinant activated factor V ...... philic neurosurgical patients.
@en
Recombinant activated factor V ...... philic neurosurgical patients.
@nl
type
label
Recombinant activated factor V ...... philic neurosurgical patients.
@en
Recombinant activated factor V ...... philic neurosurgical patients.
@nl
prefLabel
Recombinant activated factor V ...... philic neurosurgical patients.
@en
Recombinant activated factor V ...... philic neurosurgical patients.
@nl
P2093
P2860
P1433
P1476
Recombinant activated factor V ...... philic neurosurgical patients.
@en
P2093
B Gregory Thompson
Hugh J Garton
Julian T Hoff
Matthew E Fewel
P2860
P304
34-8; discussion 38-9
P356
10.1227/01.NEU.0000068830.54968.A8
P407
P577
2003-07-01T00:00:00Z